韦广莹，卢荣恒. 瑞托伐他汀对感染性休克患者免疫功能的影响及其机制探讨[J]. 中国急救医学, 2016, 36(4): 299-302.
WEI Guang- ying，LU Rong- heng. Effect and mechanism of Rosuvastatin on the immunity index in patients with septic shock . Chinese Journal of Critical Care Medicine, 2016, 36(4): 299-302.
[1] Pravda J. Metabolic theory of septic shock[J]. World J Crit Care Med，2014，3（2）: 45-54.
[2] Azevedo LC. The many facets of sepsis pathophysiology and treatment[J]. Shock，2013，39（Suppl 1）：1-2.
[3] Marik PE. Early management of severe sepsis: concepts and controversies[J]. Chest ，2014 ，
145（6）: 1407-1418.
[4] Piechota M，Barylski M，Hannam S，et al. Rationale of statin therapy in septic patients[J]. Curr Vasc
Pharmacol，2013，11（5）:795-800.
[5] Bromilow J，Schuster Bruce M. The use of statins in intensive care unit patients with sepsis[J]. Anaesth
Intensive Care，2007，35（2）：256-258.
[6] Dellinger RP ， Levy MM ， Rhodes A ， et al. Surviving sepsis campaign: international guidelines for
management of severe sepsis and septic shock: 2012[J]. Crit Care Med，2013，41（2）: 580-637.
[7] Dellinger RP ， Levy MM ， Carlet JM ， et al. Surviving Sepsis Campaign: international guidelines for
management of severe sepsis and septic shock: 2008[J]. Crit Care Med，2008，36（1）:296-327.
[8] Uehara S，Gothoh K，Handa H，et al. Immune function in patients with acute pancreatitis[J].
J Gastroenterol Hepatol，2003，18（4）：363-370.
[9] 韦广莹，卢荣恒，谭宜将.免疫强化肠内营养在感染性休克中临床应用[J].中国急救医学，2015，36（9）：802-807.
[10] Hotchkiss RS，Swanson PE，Cobb JP，et al. Apoptosis in lymphoid and parenchymal cells during
sepsis:finddings in normal and T- and B-cell-deficient mice[J]. Crit Care Med，1997，25（8）:1298-1307.
[11] Weitz- Schmidt G ， Welzenbach K ， Brinkmann V ， et al.Statins selectively inhibit leukocyte function
antigen-1 by binding to a novel regulatory integrin site[J]. Nature Med，2001，7（6）:687-692.
[12] 张丽娜，吴铁军，张保军，等.严重多发伤患者 Th17细胞的变化特点及其与继发脓毒症的关系[J].中国急救医学，2012，
32（6）：502-505.
[13] Zhou Q，Liao JK. Pleiotropic effects of statins. - Basic research and clinical perspectives[J].
Circ J，2010，74（5）:818-826.
[14] Geissler I，Collins L，Schofield R，et al. In vivo suppression of major histocompatibility complex
class Ⅱ expression on porcine vascular endothelial cells by an HMG- CoA reductase inhibitor[J].
Transplantation，2006，81（6）:922-926.
[15] Antonopoulos AS，Margaritis M，Lee R，et al. Statins as anti- inflammatory agents in
atherogenesis: molecular mechanisms and lessons from the recent clinical trials[J]. Curr Pharm Des，2012，18
（11）:1519-1530.
[16] Eller P，Eller K，Wolf AM，et al. Atorvastatin attenuates murine anti-glomerular basement membrane
glomerulonephritis[J]. Kidney Int，2010，77（5）:428-435.
[17] Maneechotesuwan K，Kasetsinsombat K，Wamanuttajinda V，et al.Statins enhance the effects of
corticosteroids on the balance between regulatory T cells and Th17 cells[J]. Clin Exp Allergy，
2013，43（2）:212-222.
[18] Fu Q，Cui N，Yu W，et al. Percentages of CD4+ T regulatory cells and HLA-DR expressing monocytes in
severe intra-abdominal infections[J]. Scand J Infect Dis，2010，42（6-7）:475-478.
[19] Hackam DG，Mamdani M，Li P，et al. Statins and sepsis in patients with cardiovascular disease:
a population-based cohort analysis[J].Lancet，2006，367（9508）:413-418.
[20] Cawcutt KA，Peters SG. Severe sepsis and septic shock: clinical overview and update on management[J].
Mayo Clin Proc，2014，89（11）:1572-1578.
[21] Rochwerg B，Alhazzani W，Sindi A，et al. Fluid resuscitation insepsis: a systematic review and network
meta- analysis[J]. Ann Intern Med，2014，161（5）:347-355.
